Press Releases Healius Limited

Equities

Delayed Australian S.E. Other stock markets 11:24:13 2024-05-02 pm EDT			5-day change	1st Jan Change
1.148 ^AUD	+4.32%		-9.29%	-29.82%

Mar. 06	Morgan Stanley Adjusts Healius’ Price Target to AU$1 From AU$1.30, Keeps at Underweight	MT
Mar. 05	Australia shares inch lower as miners weigh; GDP data in focus	RE

ACCC opposes Australian Clinical Labs' proposed acquisition of Healius	Dec. 15	AQ
Medical practices and pathology providers – Prohibited practices and the 'Red Book': know your obligations	Nov. 13	AQ
ACCC consults on ACL's proposed divestiture remedy for Healius acquisition	23-10-03	AQ
ACL's proposed acquisition of Healius raises concerns	23-07-20	AQ
No Enthusiasm To Combine ACL & Healius	23-03-20	AQ
Agilex - Stephen McIntyre Joins Agilex Biolabs as CEO	23-02-01	AQ
CN Diagnostics Partners with Grupo Fleury to Bring Pioneering Blood Tests to Brazil for Advancing Brain Health	22-09-22	AQ
C2N Diagnostics and Healius Ltd Announce Partnership to Bring PrecivityAD™ and Related Brain Health Biomarkers to Patients in Australia	22-08-30	BU
Healius : Application for quotation of securities - HLS	22-07-05	PU
Healius : Update - Notification of buy-back - HLS	22-06-15	PU
Healius : Update - Notification of buy-back - HLS	22-06-13	PU
Healius : Update - Notification of buy-back - HLS	22-06-08	PU
Healius : Update - Notification of buy-back - HLS	22-06-06	PU
Healius : Update - Notification of buy-back - HLS	22-06-02	PU
Healius : Update - Notification of buy-back - HLS	22-05-30	PU
Healius : Strategy Day Presentation	22-05-19	PU
Healius : Update - Notification of buy-back - HLS	22-05-01	PU
Healius : Update - Notification of buy-back - HLS	22-04-28	PU
Healius : Update - Notification of buy-back - HLS	22-04-26	PU
Healius : Update - Notification of buy-back - HLS	22-04-18	PU

No results for this search